Author ORCID Identifier
https://orcid.org/0000-0003-4042-4716
Date of Graduation
5-2020
Document Type
Dissertation (PhD)
Program Affiliation
Biochemistry and Molecular Biology
Degree Name
Doctor of Philosophy (PhD)
Advisor/Committee Chair
Michael R. Blackburn, Ph.D.
Committee Member
Holger Eltzschig, M.D., Ph.D.
Committee Member
Scott E. Evans, M.D.
Committee Member
Leng Han, Ph.D.
Committee Member
Harry Karmouty-Quintana, Ph.D.
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease which affects about 5 to 8 million individuals in the world. Despite the high prevalence, there is currently no cure for IPF, and the cause of this disease is still unclear. Our laboratory and collaborators have shown that nudix hydrolase 21 (NUDT21, which is also known as cleavage factor 25, CFIm25) is a key regulator of alternative polyadenylation (APA). NUDT21 depletion causes 3’UTR shortening via APA leading to enhanced mRNA stability and protein translation. This NUDT21 reduction promotes tumor growth in glioblastoma by enhancing expression of oncogenes. Cancer and IPF share cellular features, such as enhanced expression for pathological mediators and increased cell proliferation. However, whether APA plays a role in lung fibrosis is not known. Our results reveal that NUDT21 reduction is found in lung fibroblasts isolated from IPF patients. Depletion of NUDT21 causes 3’UTR shortening in pro-fibrotic genes, such as Wnt and TGFb1, leading to robust protein expression of the pathological genes and ultimately worsening of pulmonary fibrosis. Additionally, we found that TGFb1 depletes NUDT21 in fibroblasts by transcriptionally inducing miR203 through Smad3. Modulating NUDT21 by overexpression or antagomiR203 attenuated NUDT21 reduction-mediated fibrosis in vitro. The results of this dissertation are significant in that these findings broaden our understanding on the role of APA in fibrosis. The knowledge discovered in this project is potentially beneficial as these results may lead to identification of targets for novel therapies which can halt the progression of IPF.
Keywords
polyadenylation, pulmonary fibrosis, transforming growth factor β (TGFβ), mRNA, post-transcriptional regulation, alternative polyadenylation, APA, miR203, NUDT21
Included in
Biochemistry Commons, Cellular and Molecular Physiology Commons, Circulatory and Respiratory Physiology Commons, Laboratory and Basic Science Research Commons, Medical Biochemistry Commons, Medical Cell Biology Commons, Medical Physiology Commons, Molecular Biology Commons, Other Biochemistry, Biophysics, and Structural Biology Commons, Other Life Sciences Commons, Other Physiology Commons